BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 32131881)

  • 1. Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.
    Haeberle H; Prohaska S; Martus P; Straub A; Zarbock A; Marx G; Zago M; Giera M; Koeppen M; Rosenberger P
    Trials; 2020 Mar; 21(1):242. PubMed ID: 32131881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
    Abraham E; Baughman R; Fletcher E; Heard S; Lamberti J; Levy H; Nelson L; Rumbak M; Steingrub J; Taylor J; Park YC; Hynds JM; Freitag J
    Crit Care Med; 1999 Aug; 27(8):1478-85. PubMed ID: 10470753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PReVENT--protective ventilation in patients without ARDS at start of ventilation: study protocol for a randomized controlled trial.
    Simonis FD; Binnekade JM; Braber A; Gelissen HP; Heidt J; Horn J; Innemee G; de Jonge E; Juffermans NP; Spronk PE; Steuten LM; Tuinman PR; Vriends M; de Vreede G; de Wilde RB; Serpa Neto A; Gama de Abreu M; Pelosi P; Schultz MJ
    Trials; 2015 May; 16():226. PubMed ID: 26003545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial.
    Sinnige JS; Smit MR; Ghose A; de Grooth HJ; Itenov TS; Ischaki E; Laffey J; Paulus F; Póvoa P; Pierrakos C; Pisani L; Roca O; Schultz MJ; Szuldrzynski K; Tuinman PR; Zimatore C; Bos LDJ;
    Trials; 2024 May; 25(1):308. PubMed ID: 38715118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
    Atmowihardjo L; Schippers JR; Bartelink IH; Bet PM; van Rein N; Purdy K; Cavalla D; Comberiati V; McElroy A; Snape SD; Bogaard HJ; Heunks L; Juffermans N; Schultz M; Tuinman PR; Bos LDJ; Aman J
    Trials; 2022 Feb; 23(1):158. PubMed ID: 35172891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial.
    ART Investigators
    Trials; 2012 Aug; 13():153. PubMed ID: 22929542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
    Gates S; Perkins GD; Lamb SE; Kelly C; Thickett DR; Young JD; McAuley DF; Snaith C; McCabe C; Hulme CT; Gao Smith F
    Health Technol Assess; 2013 Sep; 17(38):v-vi, 1-87. PubMed ID: 24028755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of EIT-guided PEEP titration on prognosis of patients with moderate to severe ARDS: study protocol for a multicenter randomized controlled trial.
    Yuan X; Zhang R; Wang Y; Chen D; Chao Y; Xu J; Guo L; Liu A; Xie J; Pan C; Yang Y; Qiu H; Liu L
    Trials; 2023 Apr; 24(1):266. PubMed ID: 37041561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial.
    Villar J; Belda J; Añón JM; Blanco J; Pérez-Méndez L; Ferrando C; Martínez D; Soler JA; Ambrós A; Muñoz T; Rivas R; Corpas R; Díaz-Dominguez FJ; Soro M; García-Bello MA; Fernández RL; Kacmarek RM;
    Trials; 2016 Jul; 17():342. PubMed ID: 27449641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
    Bellani G; Laffey JG; Pham T; Fan E; Brochard L; Esteban A; Gattinoni L; van Haren F; Larsson A; McAuley DF; Ranieri M; Rubenfeld G; Thompson BT; Wrigge H; Slutsky AS; Pesenti A; ;
    JAMA; 2016 Feb; 315(8):788-800. PubMed ID: 26903337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pathophysiology-driven airway pressure release ventilation versus low tidal volume ventilation strategy for patients with moderate-severe ARDS: study protocol for a randomized, multicenter, controlled trial.
    Zhou Y; Cheng J; Zhu S; Dong M; Lv Y; Jing X; Kang Y
    BMC Pulm Med; 2024 May; 24(1):252. PubMed ID: 38783268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
    JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
    Villar J; Añón JM; Ferrando C; Aguilar G; Muñoz T; Ferreres J; Ambrós A; Aldecoa C; Suárez-Sipmann F; Thorpe KE; Jüni P; Slutsky AS;
    Trials; 2020 Aug; 21(1):717. PubMed ID: 32799933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial.
    Haeberle HA; Calov S; Martus P; Serna-Higuita LM; Koeppen M; Goll A; Bernard A; Zarbock A; Meersch M; Weiss R; Mehrländer M; Marx G; Putensen C; Bakchoul T; Magunia H; Nieswandt B; Mirakaj V; Rosenberger P
    Respir Res; 2023 Feb; 24(1):58. PubMed ID: 36805707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quality of results of therapy of acute respiratory failure : changes over a period of two decades].
    Briegel I; Dolch M; Irlbeck M; Hauer D; Kaufmann I; Schelling G
    Anaesthesist; 2013 Apr; 62(4):261-70. PubMed ID: 23558717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19-associated ARDS treated with DEXamethasone (CoDEX): study design and rationale for a randomized trial.
    Tomazini BM; Maia IS; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Cavalcanti AB; Rosa RG; Avezum Á; Veiga VC; Lopes RD; Damiani LP; Machado FR; Berwanger O; Azevedo LCP;
    Rev Bras Ter Intensiva; 2020; 32(3):354-362. PubMed ID: 33053024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iloprost improves gas exchange in patients with pulmonary hypertension and ARDS.
    Sawheny E; Ellis AL; Kinasewitz GT
    Chest; 2013 Jul; 144(1):55-62. PubMed ID: 23370599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trial.
    Algera AG; Pisani L; Bergmans DCJ; den Boer S; de Borgie CAJ; Bosch FH; Bruin K; Cherpanath TG; Determann RM; Dondorp AM; Dongelmans DA; Endeman H; Haringman JJ; Horn J; Juffermans NP; van Meenen DM; van der Meer NJ; Merkus MP; Moeniralam HS; Purmer I; Tuinman PR; Slabbekoorn M; Spronk PE; Vlaar APJ; Gama de Abreu M; Pelosi P; Serpa Neto A; Schultz MJ; Paulus F;
    Trials; 2018 May; 19(1):272. PubMed ID: 29739430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.